Authors
No matching authors found
Try adjusting your search criteria
Advertisement
Advertisement
Trending on CancerNetwork
1
Durvalumab/Carboplatin/Etoposide Prove Tolerable in ES-SCLC
2
Tarlatamab Earns Traditional FDA Approval in ES-SCLC
3
FDA Approves Sevabertinib in Non-Squamous NSCLC
4
FDA Accepts NDA for Zidesamtinib in Pretreated Advanced ROS1+ NSCLC
5
